Quantrx Biomedical (QTXB) Return on Equity ROE from the third quarter 2022 to third quarter 2021 and annually, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Quantrx Biomedical Corporation  (QTXB)

Quantrx Biomedical's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Quantrx Biomedical in the third quarter 2022?
Due to the lack of equity, it was not possible to calculate Quantrx Biomedical Corporation's return on equity (ROE) in its third quarter 2022

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 0 0 0 0 0
Return On Equity (TTM) - - - - -
QTXB's Total Ranking # # # # #
Equity (TTM) in Millions -3 -3 -3 -3 -3
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to QTXB Management Effectiveness >> QTXB's 5 Years Annual ROE >> Compare QTXB ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





QTXB Annual Return On Equity (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Equity in Millions -3 -2 -2 -2 -1
Y / Y Equity Change - - - - -
Net Income in Millions 0 0 -1 -1 1
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to QTXB Management Effectiveness >> QTXB's 5 Years Annual ROE >> Compare QTXB ROE to its Competitors




Annual Roe Comment
Despite deterioration in net income, company improved ROE to in 2021, company improved ROE to 1 % compared to the prior year.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
QTXB's' Return on Equity at Yahoo Finance
QTXB's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for QTXB's Competitors
Subscribers only: Roe for Quantrx Biomedical's Suppliers
Subscribers only: Return On Equity for QTXB's Customers




Companies with similar Return On Equity at Sep 30 2022, within Healthcare Sector ROE
Zynex inc   26.05 %
Johnson and Johnson  25.57 %
Semler Scientific inc   25.49 %
Lftd Partners Inc   25.36 %
Edwards Lifesciences Corporation  24.47 %
Gyre Therapeutics Inc   24.38 %
Resmed Inc   24.27 %
Organogenesis Holdings Inc   23.99 %
Agilent Technologies inc   23.99 %
Quidelortho Corp  23.04 %
Incyte Corporation  21.98 %
Abbott Laboratories  21.88 %
Reflect Scientific Inc  21.74 %
Assertio Holdings inc   21.51 %
Fulgent Genetics Inc   21.27 %
Abcellera Biologics Inc   21.15 %
Quest Diagnostics Inc  20.48 %
Iqvia Holdings Inc   20.44 %
Biogen Inc   20.44 %
Bristol myers Squibb Company  20.12 %
Cullinan Therapeutics Inc   20.06 %
Rayont Inc   19.97 %
Sotera Health Company  19.77 %
Lantheus Holdings Inc   19.59 %
Ensign Group Inc  19.39 %
Iradimed Corporation  19.30 %
Docgo Inc   19.29 %
Patterson Companies Inc   19.05 %
Atrion Corporation  18.84 %
Integrated Biopharma Inc  18.72 %

Date modified: 2026-09-08T15:10:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.